For the year ending 2025-12-31, KYNB made $6,440K in revenue. $183,452K in net income. Net profit margin of 2848.63%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 6,440 | |||
| Cost of goods sold | 556 | |||
| Research and development | 23,517 | |||
| Selling, general and administrative | 27,709 | |||
| Restructuring charge | 553 | |||
| Total operating costs and expenses | 52,335 | |||
| Loss from operations | -45,895 | |||
| Interest expense | 8,759 | |||
| Loss on debt extinguishments | -6,583 | |||
| Interest income and other income (expenses), net | 2,943 | |||
| Total interest and other, net | -12,399 | |||
| Loss from continuing operations before income taxes | -58,294 | |||
| Benefit from income taxes | -90 | |||
| Loss from continuing operations | -58,204 | |||
| Product revenue, net | 226,651 | |||
| Cost of goods sold | 13,454 | |||
| Research and development | 1,739 | |||
| Selling, general and administrative | 14,849 | |||
| Total operating costs and expenses | 30,042 | |||
| Income from operations | 196,609 | |||
| Interest expense | 7,816 | |||
| Gain on divestiture | 52,553 | |||
| Interest income and other income (expenses), net | 2,173 | |||
| Total interest and other, net | -42,564 | |||
| Income before income taxes | 239,173 | |||
| Provision for income taxes | 0 | |||
| Investment income in unconsolidated variable interest entity | 2,483 | |||
| Income from discontinued operations, net of tax | 241,656 | |||
| Net income (loss) | 183,452 | |||
| Basic EPS | 45.37 | |||
| Diluted EPS | 45.37 | |||
| Basic Average Shares | 4,043,000 | |||
| Diluted Average Shares | 4,043,000 | |||
KYNTRA BIO, INC. (KYNB)
KYNTRA BIO, INC. (KYNB)